Discover the advanced therapies happening at IRR Core Facilities Supporting your advanced therapies pipeline Healthcare Technology Accelerator Facility The Healthcare Technology Accelerator Facility (HTAF) is a vibrant initiative aimed at expediting the development of healthcare technology within the University of Edinburgh BioQuarter. It consists of three main divisions: the Active Pharmaceutical Ingredient (API) Manufacturing Lab, Sterile Drug Manufacturing GMP Facility, and Investigational Supplies Group (ISG). Catapult Laboratories, offices and expert teams to support the development of robust cell therapy manufacturing processes and accelerated routes to the clinic. EuroGCT EuroGCT provides reliable and accessible information about the use of cells and genetic material to treat disease - for the public, patients and researchers REACT The MRC/BHF CoRE in Advanced Cardiac Therapies (REACT) unites academic, healthcare, industry and public partners to develop innovative DNA and RNA-based therapies to regenerate injured hearts and reverse established damage. This article was published on 2026-02-24
